CNM
Core & Main, Inc.
CNM has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CNM overall, supported by stronger fundamentals and stronger valuation.
CNM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
CNM's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CNM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $44.62 | — |
| Cheap | 16x | $39.56 | -11% |
| Current | 18x | $44.62 | — |
| Fair | 22x | $54.21 | +21% |
| Expensive | 27x | $65.05 | +46% |
Historical ranges are pointers, not guarantees.
CNM's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CNM in the historical PE scenario, which offers more potential upside but is not a forecast.
CNM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect CNM's earnings to grow and its profitability to improve, with its revenue holding steady.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over CNM on the outlook, with more favorable revenue expectations.
CNM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.29 | +36% |
| Q3 2026 | $2.43 | +8% |
| Q2 2026 | $2.36 | +9.3% |
| Q1 2026 | $2.31 | +8.5% |
| Q4 2025 | $2.28 | +7% |
| Q3 2025 | $2.25 | +7.7% |
| Q2 2025 | $2.16 | +0.9% |
| Q1 2025 | $2.13 | -0.9% |
| Q4 2024 | $2.13 | +0.5% |
CNM earned $2.43 per share over the past year, up 8% from the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CNM on earnings, with more consistent year-over-year improvement.
CNM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | +2.5% |
| Q2 2026 | $1.9B | -0.1% |
| Q1 2026 | $1.6B | -6.9% |
| Q4 2025 | $2.1B | +1.2% |
| Q3 2025 | $2.1B | +6.6% |
| Q2 2025 | $1.9B | +9.8% |
| Q1 2025 | $1.7B | +18% |
| Q4 2024 | $2B | +12% |
CNM's revenue grew through 2024 and has held roughly level since: $2.1B last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +0.4 points |
| Q2 2026 | 9.3% | +0.3 points |
| Q1 2026 | 7.5% | +0.2 points |
| Q4 2025 | 11% | -0.3 points |
| Q3 2025 | 10% | -0.2 points |
| Q2 2025 | 8.9% | -0.7 points |
| Q1 2025 | 7.3% | -0.8 points |
| Q4 2024 | 11% | -0.9 points |
CNM's operating margin was 11% last quarter, about level with the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CNM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CNM on profitability, with a higher operating margin.
CNM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44M | +83% |
| Q2 2026 | $68M | +6.3% |
| Q1 2026 | $253M | +13% |
| Q4 2025 | $263M | +4.4% |
| Q3 2025 | $24M | -38% |
| Q2 2025 | $64M | -9.9% |
| Q1 2025 | $224M | -22% |
| Q4 2024 | $252M | -29% |
CNM still generates free cash flow, though less than at its 2023 peak: $628M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CNM on cash flow, with more consistent year-over-year improvement.
CNM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -2.3M shares |
| 1 year | -2.5% | -4.9M shares |
| 3 years | -16% | -35.6M shares |
| 5 years | +39% | +54.4M shares |
| Available history | +21% | +33.3M shares |
CNM has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $169M |
| Q2 2026 | $88M |
| Q1 2026 | $58M |
| Q4 2025 | $50M |
| Q3 2025 | $8M |
| Q2 2025 | $39M |
| Q1 2025 | $55M |
| Q4 2024 | $100M |
CNM spent $365M buying back its own shares over the past year, up 81% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CNM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.7x | Moderate |
CNM's net debt is about 2.3 years of its operating earnings (EBITDA), about the same as a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CNM on leverage, with a lower net debt burden relative to earnings.
CNM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 58.7 | Neutral |
CNM's weekly RSI is 49 (neutral) and its Stochastic is 59 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CNM PE vs Industrials Sector
| Metric | CNM | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 24% below |
| PE % | 23 | 63 | 40 pts below |
CNM has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CNM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.9 | 4% above |
| 20 week MA | $43.7 | 2% above |
| 50 week MA | $48.6 | 8.2% below |
| 100 week MA | $51.5 | 13% below |
| 200 week MA | $45.2 | 1.4% below |
CNM has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 1.4% below its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CNM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $23.7 | $29.5 | +25% |
| 2022 | $29.5 | $19.2 | -35% |
| 2023 | $19.2 | $40.4 | +111% |
| 2024 | $40.4 | $51.0 | +26% |
| 2025 | $51.0 | $54.0 | +5.8% |
| 2026 YTD | $54.0 | $44.6 | -17% |
CNM has finished higher in four of the last five years. It's down 17% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CNM on returns for 2026, with the stronger performance.